Patients’ knowledge and perspectives on wet age-related macular degeneration and its treatment
Sushma Kandula1, Jeffrey C Lamkin1, Teresa Albanese2, Deepak P Edward11Department of Ophthalmology, 2Health Service Research and Education Institute, SUMMA Health System, Akron OH, USASummary: There have been no studies examining the level of understanding age-related macular degeneration (ARMD) pat...
Saved in:
Main Authors: | Sushma Kandula, Jeffrey C Lamkin, Teresa Albanese, et al |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/2d1591327bb04dd7864d2dba72fc85c7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives
by: Neffendorf JE, et al.
Published: (2015) -
Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration
by: Keles S, et al.
Published: (2014) -
Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration [Corrigendum]
by: Dervenis N, et al.
Published: (2016) -
Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept
by: Stewart MW
Published: (2012) -
Spectral domain OCT versus time domain OCT in the evaluation of macular features related to wet age-related macular degeneration
by: Isola V, et al.
Published: (2012)